Thyrotrophs in PIT1‐lineage Pituitary Neuroendocrine Tumours Without Syndrome of Inappropriate Secretion of Thyrotropin Stimulating Hormone
Clinical Endocrinology · 2025
DOI: 10.1111/cen.15283 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Endocrinology, 2025. Verfasst von Eri Kasuga und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Moriyama Memorial Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Pituitary Neoplasms, Thyrotropin, Neuroendocrine Tumors, Thyrotrophs. Die Arbeit nennt 15 Literaturangaben. Gefördert von: This study was supported by MHLW (grant number: 23FC1042) and MEXT KAKENHI (grant number: 19K07427)..
Abstract (Originalsprache)
Objective
Many patients with pituitary neuroendocrine tumours (PitNETs) containing beta (β) thyroid‐stimulating hormone (TSH)‐immunopositive cells, without syndrome of inappropriate secretion of TSH (SITSH), show a significant reduction in TSH levels following surgical removal of the tumour‐like functioning thyrotroph PitNET. We evaluated the pathophysiological and clinical characteristics of TSH‐positive cells in PIT1‐lineage PitNETs in patients without the syndrome of inappropriate secretion of TSH.
Design
Retrospective cohort study. Patients and Mesurements Overall, 165 patients diagnosed with PIT1‐lineage PitNETs without SITSH between April 2018 and July 2023 at Moriyama Memorial Hospital were reviewed. They were categorised into three groups based on the rate of βTSH‐immuno‐positive cells in their PitNETs: strongly positive group with 10% or more βTSH‐immuno‐positive cells, weakly positive group with less than 10%, and negative group. Clinical data from these groups were compared.
Results
Patient age, sex, and tumour size did not differ significantly among the groups. Most of the weakly positive cases had acromegaly, whereas many of the strongly positive cases had clinically nonfunctioning tumours. Preoperative TSH levels were slightly higher in strongly positive cases than in the other groups but fell within the normal range postoperatively, whereas postoperative TSH levels were significantly lower across all groups. The degree of TSH reduction postoperatively was significantly higher in the strongly positive group.
Conclusions
In the strongly positive group, TSH levels decreased significantly after surgery, whereas no such decrease was observed in the other two groups, suggesting that thyrotrophs in strongly positive PitNETs are TSH‐producing, similar to clinically functioning thyrotroph PitNETs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Moriyama Memorial Hospital, Tokyo, Japan.
- Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
- Department of Endocrinology, Moriyama Memorial Hospital, Tokyo, Japan.
- Department of Hypothalamic and Pituitary Surgery, Moriyama Memorial Hospital, Tokyo, Japan.
ORCID-Profile: Naoko Inoshita
Förderung
- This study was supported by MHLW (grant number: 23FC1042) and MEXT KAKENHI (grant number: 19K07427).
Zitieren
APA
Kasuga, E., Inoshita, N., Tanabe, N., Ishida, A., Kato, M., Yoshimoto, H., Shiramizu, H., Matsuoka, G., Takano, K., Yamada, S., & Nishimura, R. (2025). Thyrotrophs in PIT1‐lineage Pituitary Neuroendocrine Tumours Without Syndrome of Inappropriate Secretion of Thyrotropin Stimulating Hormone. Clinical Endocrinology. https://doi.org/10.1111/cen.15283
Vancouver
Kasuga E, Inoshita N, Tanabe N, Ishida A, Kato M, Yoshimoto H, et al. Thyrotrophs in PIT1‐lineage Pituitary Neuroendocrine Tumours Without Syndrome of Inappropriate Secretion of Thyrotropin Stimulating Hormone. Clinical Endocrinology. 2025. doi:10.1111/cen.15283
BibTeX
@article{Kasuga2025,
author = {Kasuga, Eri and Inoshita, Naoko and Tanabe, Noriaki and Ishida, Atsushi and Kato, Masataka and Yoshimoto, Haruko and Shiramizu, Hideki and Matsuoka, Go and Takano, Koji and Yamada, Shozo and Nishimura, Rimei},
title = {Thyrotrophs in PIT1‐lineage Pituitary Neuroendocrine Tumours Without Syndrome of Inappropriate Secretion of Thyrotropin Stimulating Hormone},
journal = {Clinical Endocrinology},
year = {2025},
doi = {10.1111/cen.15283}
}
EUVIMED